• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发射α粒子的砹-211标记抗体在肿瘤球体中的细胞毒性:热疗无影响。

Cytotoxicity of alpha-particle-emitting astatine-211-labelled antibody in tumour spheroids: no effect of hyperthermia.

作者信息

Hauck M L, Larsen R H, Welsh P C, Zalutsky M R

机构信息

Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

Br J Cancer. 1998 Mar;77(5):753-9. doi: 10.1038/bjc.1998.123.

DOI:10.1038/bjc.1998.123
PMID:9514054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2149964/
Abstract

The high linear energy transfer, alpha-particle-emitting radionuclide astatine-211 (211At) is of interest for certain therapeutic applications; however, because of the 55- to 70-microm path length of its alpha-particles, achieving homogeneous tracer distribution is critical. Hyperthermia may enhance the therapeutic efficacy of alpha-particle endoradiotherapy if it can improve tracer distribution. In this study, we have investigated whether hyperthermia increased the cytotoxicity of an 211At-labelled monoclonal antibody (MAb) in tumour spheroids with a radius (approximately 100 microm) greater than the range of 211At alpha-particles. Hyperthermia for 1 h at 42 degrees C was used because this treatment itself resulted in no regrowth delay. Radiolabelled chimeric MAb 81C6 reactive with the extracellular matrix antigen tenascin was added to spheroids grown from the D-247 MG human glioma cell line at activity concentrations ranging from 0.125 to 250 kBq ml(-1). A significant regrowth delay was observed at 125 and 250 kBq ml(-1) in both hyperthermia-treated and untreated spheroids. For groups receiving hyperthermia, no increase in cytotoxicity was seen compared with normothermic controls at any activity concentration. These results and those from autoradiographs indicate that hyperthermia at 42 degrees C for 1 h had no significant effect on the uptake or distribution of this antitenascin MAb in D-247 MG spheroids.

摘要

高传能线密度、发射α粒子的放射性核素砹-211(²¹¹At)在某些治疗应用中具有吸引力;然而,由于其α粒子的路径长度为55至70微米,实现示踪剂的均匀分布至关重要。如果热疗能够改善示踪剂分布,那么它可能会增强α粒子内放射治疗的疗效。在本研究中,我们调查了热疗是否会增加²¹¹At标记的单克隆抗体(MAb)在半径(约100微米)大于²¹¹At α粒子射程的肿瘤球体中的细胞毒性。使用42℃热疗1小时,因为这种治疗本身不会导致再生长延迟。将与细胞外基质抗原腱生蛋白反应的放射性标记嵌合单克隆抗体81C6以0.125至250 kBq ml⁻¹的活性浓度添加到由D-247 MG人胶质瘤细胞系生长的球体中。在125和250 kBq ml⁻¹时,热疗处理和未处理的球体均观察到明显的再生长延迟。对于接受热疗的组,在任何活性浓度下与常温对照组相比均未观察到细胞毒性增加。这些结果以及放射自显影片的结果表明,42℃热疗1小时对这种抗腱生蛋白单克隆抗体在D-247 MG球体中的摄取或分布没有显著影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd2c/2149964/4fb4e3f1e81c/brjcancer00081-0079-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd2c/2149964/cd2c431c5024/brjcancer00081-0079-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd2c/2149964/4fb4e3f1e81c/brjcancer00081-0079-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd2c/2149964/cd2c431c5024/brjcancer00081-0079-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd2c/2149964/4fb4e3f1e81c/brjcancer00081-0079-b.jpg

相似文献

1
Cytotoxicity of alpha-particle-emitting astatine-211-labelled antibody in tumour spheroids: no effect of hyperthermia.发射α粒子的砹-211标记抗体在肿瘤球体中的细胞毒性:热疗无影响。
Br J Cancer. 1998 Mar;77(5):753-9. doi: 10.1038/bjc.1998.123.
2
The cytotoxicity and microdosimetry of astatine-211-labeled chimeric monoclonal antibodies in human glioma and melanoma cells in vitro.
Radiat Res. 1998 Feb;149(2):155-62.
3
Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate.使用发射α粒子的免疫偶联物对大鼠肿瘤性脑膜炎进行放射免疫治疗。
Cancer Res. 1994 Sep 1;54(17):4719-25.
4
Radiotoxicity of systemically administered 211At-labeled human/mouse chimeric monoclonal antibody: a long-term survival study with histologic analysis.全身给药的211At标记人/鼠嵌合单克隆抗体的放射毒性:一项组织学分析的长期生存研究。
Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):491-9. doi: 10.1016/s0360-3016(99)00206-0.
5
Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy.砹-211标记的放射治疗药物:靶向α粒子放射治疗的一种新兴方法。
Curr Pharm Des. 2000 Sep;6(14):1433-55. doi: 10.2174/1381612003399275.
6
Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6.发射α粒子的砹-211的临床经验:用砹-211标记的嵌合抗腱生蛋白单克隆抗体81C6治疗复发性脑肿瘤患者。
J Nucl Med. 2008 Jan;49(1):30-8. doi: 10.2967/jnumed.107.046938. Epub 2007 Dec 12.
7
Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At.使用α粒子发射体211砹进行血管靶向放射免疫治疗。
Radiat Res. 2002 Jun;157(6):633-41. doi: 10.1667/0033-7587(2002)157[0633:vtrwta]2.0.co;2.
8
Comparison of the therapeutic efficacy of 211At- and 131I-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian cancer.211At和131I标记的单克隆抗体MOv18对人卵巢癌腹腔生长裸鼠的治疗效果比较
Anticancer Res. 2001 Jan-Feb;21(1A):409-12.
9
Local hyperthermia improves uptake of a chimeric monoclonal antibody in a subcutaneous xenograft model.
Clin Cancer Res. 1997 Jan;3(1):63-70.
10
Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity.用发射α粒子的核素砹-211标记单克隆抗体和F(ab')2片段:免疫反应性和体内定位能力的保留
Proc Natl Acad Sci U S A. 1989 Sep;86(18):7149-53. doi: 10.1073/pnas.86.18.7149.

引用本文的文献

1
Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer.用于癌症导向放射性核素治疗的放射性诊断和治疗药剂。
Curr Med Chem. 2020;27(41):7003-7031. doi: 10.2174/0929867327999200727190423.
2
Targeted and Nontargeted α-Particle Therapies.靶向和非靶向α粒子疗法。
Annu Rev Biomed Eng. 2018 Jun 4;20:73-93. doi: 10.1146/annurev-bioeng-062117-120931. Epub 2018 Jan 18.
3
Automated cassette-based production of high specific activity [Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer.

本文引用的文献

1
Local hyperthermia improves uptake of a chimeric monoclonal antibody in a subcutaneous xenograft model.
Clin Cancer Res. 1997 Jan;3(1):63-70.
2
Evaluation of an internal cyclotron target for the production of 211At via the 209Bi (alpha,2n)211 at reaction.用于通过²⁰⁹Bi(α,2n)²¹¹At反应生产²¹¹At的内部回旋加速器靶的评估。
Appl Radiat Isot. 1996 Feb;47(2):135-43. doi: 10.1016/0969-8043(95)00285-5.
3
The effects of clinically relevant hyperthermic temperatures on the kinetic binding parameters of a monoclonal antibody.临床相关高温对单克隆抗体动力学结合参数的影响。
基于自动盒式生产高比活度的[铅]基于肽的治疗诊断放射性药物,用于癌症的影像引导放射性核素治疗。
Appl Radiat Isot. 2017 Sep;127:52-60. doi: 10.1016/j.apradiso.2017.05.006. Epub 2017 May 10.
4
Transcriptional Response in Mouse Thyroid Tissue after 211At Administration: Effects of Absorbed Dose, Initial Dose-Rate and Time after Administration.211At给药后小鼠甲状腺组织的转录反应:吸收剂量、初始剂量率及给药后时间的影响
PLoS One. 2015 Jul 15;10(7):e0131686. doi: 10.1371/journal.pone.0131686. eCollection 2015.
5
Mild hyperthermia influence on Herceptin(®) properties.轻度升温对赫赛汀(®)特性的影响。
Radiol Oncol. 2015 Mar 3;49(1):41-9. doi: 10.2478/raon-2014-0045. eCollection 2015 Mar.
6
Astatine Radiopharmaceuticals: Prospects and Problems.砹放射性药物:前景与问题
Curr Radiopharm. 2008 Sep 1;1(3):177. doi: 10.2174/1874471010801030177.
7
Cancer radioimmunotherapy with alpha-emitting nuclides.使用发射α粒子的核素进行癌症放射免疫治疗。
Eur J Nucl Med Mol Imaging. 2005 May;32(5):601-14. doi: 10.1007/s00259-005-1803-2.
Nucl Med Biol. 1996 May;23(4):551-7. doi: 10.1016/0969-8051(96)00039-x.
4
Penetration and binding of monoclonal antibody in human osteosarcoma multicell spheroids. Comparison of confocal laser scanning microscopy and autoradiography.单克隆抗体在人骨肉瘤多细胞球体中的穿透与结合。共聚焦激光扫描显微镜与放射自显影的比较。
Acta Oncol. 1996;35(3):273-9. doi: 10.3109/02841869609101641.
5
Quantitative recording of vitality patterns in living multicellular spheroids by confocal microscopy.通过共聚焦显微镜对活的多细胞球体中的活力模式进行定量记录。
Micron. 1995;26(5):395-404. doi: 10.1016/0968-4328(95)00009-7.
6
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report.用131I放射性标记的抗腱生蛋白单克隆抗体81C6和抗硫酸软骨素蛋白聚糖Me1-14 F(ab')2治疗恶性胶质瘤和肿瘤性脑膜炎的I期研究——初步报告
J Neurooncol. 1995;24(1):109-22. doi: 10.1007/BF01052668.
7
Effect of cell arrangement and interstitial volume fraction on the diffusivity of monoclonal antibodies in tissue.细胞排列和组织间隙体积分数对单克隆抗体在组织中扩散率的影响。
Biophys J. 1993 May;64(5):1638-46. doi: 10.1016/S0006-3495(93)81532-7.
8
Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate.使用发射α粒子的免疫偶联物对大鼠肿瘤性脑膜炎进行放射免疫治疗。
Cancer Res. 1994 Sep 1;54(17):4719-25.
9
Radioimmunotherapy of prostatic adenocarcinomas: effects of 131I-labelled E4 antibodies on cells at different depth in DU 145 spheroids.
Int J Cancer. 1995 Nov 3;63(3):387-94. doi: 10.1002/ijc.2910630315.
10
Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin.针对细胞外基质蛋白腱生蛋白的小鼠/人嵌合抗体的产生与特性分析
J Neuroimmunol. 1994 Jul;52(2):127-37. doi: 10.1016/0165-5728(94)90106-6.